Category Archives: Global News Feed

NEW YORK, NY, Nov. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, has today reported continued strength and accelerating growth in its highest margin E-Commerce business segment (“E-Comm”).  The Company generated strong monthly E-Comm sales for the recently completed month of October 2021.  As of today’s date, November 5, 2021, the Company is firmly on track to generate record quarterly E-Comm sales – for its current operating quarter (October 1st– December 31st 2021).

See the original post:
Tauriga Sciences, Inc. Reports Continued Strength and Accelerating Growth in its Highest Margin E-Commerce Business Segment

Monthly information related to total number of voting rights and shares composing the share capital – October 30, 2021.

More:
Monthly information related to total number of voting rights and shares composing the share capital – October 30, 2021

Eyenovia will release third quarter 2021 results on Wednesday, November 10, after the close. The prior version of this press release incorrectly stated that third quarter 2021 results would be released on Thursday, November 11, after the close.

The rest is here:
CORRECTING AND REPLACING: Eyenovia to Report Third Quarter 2021 Results on Wednesday, November 10

Company conference call and webcast at 4:30 PM ET Company conference call and webcast at 4:30 PM ET

Read more here:
TFF Pharmaceuticals to Hold Third Quarter 2021 Financial and Business Results Conference Call on November 15, 2021

BERKELEY, Calif. and MAINZ, Germany, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostics company specializing in the early detection of cancer, today announced that its common stock commenced trading on the Nasdaq Capital Market today under the ticker symbol MYNZ. The shares closed above the offering price at $9.99.

Read the original here:
MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in the following upcoming investor conferences in November:

Continued here:
atai Life Sciences to Participate in Upcoming November Investor Conferences